Eli Lilly & Co. (LLY)
874.88
+6.61
(+0.76%)
USD |
NYSE |
Apr 28, 16:00
873.50
-1.38
(-0.16%)
After-Hours: 20:00
Eli Lilly Research and Development Expense (TTM) : 13.34B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Viking Therapeutics, Inc. | 344.96M |
| Apellis Pharmaceuticals, Inc. | 295.85M |
| Arcellx, Inc. | 157.61M |
| Moderna, Inc. | 2.917B |